Strategic positioning of a CMO and recommendation

Situation

• Our client had a niche CMO activity with approximately 300 FTEs and was part of a European biopharmaceutical company
• Despite being a leader in its segment, our client had a history of stagnant sales and low profitability
• The company was seeking assistance in determining the best strategic alternatives
  

Bionest Contribution

• Bionest advised on the overall strategy to adopt via a 2-step process :

1. Identification of strategic options
2. Detailed valuation of strategic options

• Our work was presented in comprehensive reports detailing the criteria to select the best alternative

Key Results

• The group’s board of directors was able to make an informed decision about the business
• The synergies with the global strategy of the company were poor and the CMO activity was finally sold to a competitor to form the market leader